Clinical Trial: The Effect of Enhanced Intravenous Insulin Therapy on the Prognosis of Patients with Sepsis and a High Stress-Hyperglycemia Ratio (China)

China, Sept. 25 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The Effect of Enhanced Intravenous Insulin Therapy on the Prognosis of Patients with Sepsis and a High Stress-Hyperglycemia Ratio'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133395

Registration Time: 2026/09/24

Type: Observational study

Primary Sponsor: Wuxi people’s Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338704

Published by HT Digital Content Services with permission from Health Daily Digest....